Kiselak Tomas

Related Filers (10)

Ownership (18)

4
Wednesday, 1/31/2024
Apogee Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/24/2024
Dianthus Therapeutics, Inc. /DE/: Statement of changes in beneficial ownership of securities
4
Friday, 12/29/2023
Spyre Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/11/2023
Spyre Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/28/2023
Spyre Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
Dianthus Therapeutics, Inc. /DE/: Statement of changes in beneficial ownership of securities
4
Thursday, 9/28/2023
Dianthus Therapeutics, Inc. /DE/: Statement of changes in beneficial ownership of securities
4
Thursday, 9/21/2023
Dianthus Therapeutics, Inc. /DE/: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/13/2023
Dianthus Therapeutics, Inc. /DE/: Initial statement of beneficial ownership of securities
4
Wednesday, 9/13/2023
Dianthus Therapeutics, Inc. /DE/: Statement of changes in beneficial ownership of securities
4
Monday, 7/17/2023
Apogee Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 6/30/2023
Aeglea BioTherapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/16/2023
Viridian Therapeutics, Inc.\DE: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Viridian Therapeutics, Inc.\DE: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/16/2021
Viridian Therapeutics, Inc.\DE: Statement of changes in beneficial ownership of securities
4
Monday, 2/8/2021
Viridian Therapeutics, Inc.\DE: Statement of changes in beneficial ownership of securities
4
Thursday, 10/29/2020
MIRAGEN THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/28/2020
MIRAGEN THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
Show More